Start Date
September 30, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
GMRx-4 IR polypill - sitagliptin, dapagliflozin, metformin
As described previously
Metformin
As described previously - Experimental Arm, 175mg at night
Metformin
As described previously - Active Comparator Arm, 500mg in the morning and 500mg at night
Collaborators (1)
Brandon Biocatalyst
UNKNOWN
The George Institute
OTHER
George Medicines PTY Limited
INDUSTRY